Sounds like most small biotech companies that have yet to bring a product to market. The question is will this time be different as they have alternative financing set up with the partners in China and Malaysia.
When did he become CEO? At the end of 2017 At that time what was stock price? 18-20$ How many years he has been CEO? More than 3 years now What’s stock price now? 0.286
If he can’t get stock price up? Does he deserve to be CEO? Stockholders own the company. How much stock does he own?
Market Data 
Markets 
AI
